Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Centauri Therapeutics

Centauri Therapeutics
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
$1.22M LATEST DEAL AMOUNT
5 INVESTORS
Description

Operator of biotechnology company intended to discover and develop novel molecules targeting life threatening diseases. The company's biotechnology service uses alphamer technology in which chemically synthesised molecules redirect naturally occurring antibodies to selected pathogens to fight the infections, enabling doctors to treat infectious diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Discovery Park
  • Kent CT13 9ND
  • England, United Kingdom

+44 01304 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Centauri Therapeutics’s full profile, request a free trial.

Centauri Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 11-Sep-2017 $1.22M 00.00 Completed Startup
2. Seed Round 09-Mar-2017 00.00 00.00 Completed Startup
1. Seed Round 20-Feb-2017 $1.5M $1.5M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Centauri Therapeutics Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNAtrix Venture Capital-Backed Houston, TX 00 000.00 00000000000 000.00
0000000 Venture Capital-Backed Newhouse, United Kingdom 0 000.00 0000000000 0 000.00
00000 Venture Capital-Backed Cambridge, United Kingdom 000 00000 0000000000 0 00000
00000 00000 000000 Venture Capital-Backed Geneva, Switzerland 000 00000 0000000000 0 00000
0000000 Venture Capital-Backed San Diego, CA 00 00000 0000000000 0 00000
To view this company’s complete list of competitors, request access »

Centauri Therapeutics Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 000000000 02-Mar-2016 00000 0000000 00000 Biotechnology 0000000 000000 00.0
Altermune Technologies 18-Jan-2016 Buyout/LBO Therapeutic Devices 0000000 000000 00.0
To view this company’s complete investment and acquisition history, request access »

Centauri Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Innovate UK Government 000 0000 000000 0
NCL Technology Ventures Venture Capital Minority 000 0000 000000 0
Renaissance Capital Partners Growth/Expansion Minority 000 0000 000000 0
Animatrix Capital Venture Capital Minority 000 0000 000000 0
Discovery Park Other Minority 000 0000 000000 0

Centauri Therapeutics Executive Team (2)

Name Title Board
Seat
Contact
Info
Michael Westby Ph.D Board Member & Chief Executive Officer
Stuart Lawson Board Member & Chief Financial Officer

Centauri Therapeutics Board Members (4)

Name Representing Role Since Contact
Info
Clive Dix Ph.D Centauri Therapeutics Chairman 000 0000
Michael Westby Ph.D Centauri Therapeutics Board Member & Chief Executive Officer 000 0000
Stuart Lawson Self Board Member & Chief Financial Officer 000 0000

1 Former Board Member

You’re viewing 3 of 4 board members. Get the full list »